CBM (Consorzio per il Centro di Biomedicina Molecolare), acknowledged by Regional Law 26/2005 and identified as Innovation District in Regional Law 3 of 02/20/2015, has the role of developing the potential of the Smart Health Cluster in the Italian Region of Friuli Venezia Giulia in the biomedicine, biotechnology and bioinformatics sectors. In this context, CBM has the task of creating close links between the industrial and research systems, as well as regional and national institutions in order to develop synergies covering the regional health sector. CBM is in charge of the “Smart Health” area in the framework of FVG region’s Smart Specialization Strategy (S3) and plays a leading role in building relationships between all the actors in this field - entrepreneurs, researchers, clinicians, policy makers and people involved in finance and education - with the goal of promoting business innovation and social and economic growth at a regional level. In line with S3, CBM contributes to developing a Regional innovation ecosystem in the following technological development trajectories: - Biomedical technologies, in vivo and in vitro diagnostics; - Medical informatics and bioinformatics; - Innovative therapy; - Technologies for Ambient Assisted Living (AAL).